Regulatory advisers across industry sectors are challenged to meet the regulation on endocrine disrupting chemicals (EDCs) as they pose a threat to both humans and the environment. Humans are exposed to EDCs from many sources such as cosmetics, food items, food contact materials, drinking water, toys, medical devices, pharmaceuticals and biocides and pesticides. The environment is impacted from production facilities and waste disposal.
In 2018 the scientific criteria for defining EDCs in the EU was established for biocides and pesticides, and a technical guidance document on how to assess ED properties was published by EFSA and ECHA. Though the legal definition of EDCs is established only for biocides and pesticides, EU regulatory activities are ongoing towards more harmonisation among the various legal frameworks.
Join this 45-minute webinar to learn the regulatory status of this topical issue. We will discuss how to retrieve data from different sources and show examples of how to evaluate data using the technical EFSA/ECHA guidance document. You will also be introduced to the ED mode of action (Estrogenic, Androgenic, Thyroid, Steroid), the weight of evidence approach, testing and how to identify relevant endpoints for endocrine disruption. You will benefit from participating if you need to comply with regulatory requirements for endocrine disrupting properties, whether it’s for medical devices, biocides, pesticides, chemical substances or pharmaceuticals.
• Status of the EU regulation of endocrine disrupting chemicals across industry sectors
• How to evaluate the status of your chemical substances
• How to use the technical guidance document
• Questions & Answers
Register now! There are only seats available for the first 100 attendees.
When completing this form, you agree to receive communications from DHI with inspirational articles, news and information on relevant courses, events and products. No spam. You can unsubscribe at any time.